Corient Private Wealth’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Corient Private Wealth's BCAT Position: Q2 2026 in Review
Corient Private Wealth increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 23% in Q2 2026, buying an estimated $101K and bringing the position to 34,651 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #2158.
Corient Private Wealth first reported a position in BCAT in Q1 2024 and has held it in 10 quarters since. The position peaked at $791K in Q1 2024. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Corient Private Wealth held 34,651 shares of BlackRock Capital Allocation Term Trust worth $552K as of Q2 2026.
- Corient Private Wealth bought 6,592 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $101K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2158 holding.
- Corient Private Wealth first reported a position in BlackRock Capital Allocation Term Trust in Q1 2024 and has held it in 10 quarters since.
- Corient Private Wealth's BlackRock Capital Allocation Term Trust position peaked at $791K in Q1 2024.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.